-
Aug 27, 2025
-
Company appoints Pieter De Leenheer as Chief Technology Officer and Todd Oakland as Senior Vice President and General Manager of Biopharma Business Dx/Rx
Aug 26, 2025
-
Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced its participation in the 2025 Advances in Genome Biology and Technology (AGBT) Precision Health Conference, taking place September 8–10, 2025, in San Diego, CA. The company will present important data underscoring the clinical utility of RNA sequencing in the diagnosis of rare and previously undiagnosed diseases.
Aug 24, 2025
-
Company becomes the first to centralize digital data review activities within a single platform as the industry focuses on clinical trial efficiency
Aug 20, 2025
-
Aug 19, 2025
-
Aug 14, 2025
-
Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced a clinical webinar highlighting pediatric cases in which Whole Genome Sequencing (WGS) delivered diagnostic insights that traditional genetic testing methods could not achieve.
Aug 13, 2025
-
Aug 12, 2025
-
VieCure adds Summit Cancer Centers to community oncology care network
Aug 4, 2025
-
The Axiom Space Mission 4 (Ax-4) launched from NASA’s Kennedy Space Center, and for the first time, Kaléo’s AUVI-Q® (epinephrine injection, USP) was selected by Axiom Space to support crew members in the event of an allergic emergency. Axiom Space additionally cleared AUVI-Q for inclusion on its flight surgeons’ launch and landing kits used to support the crew in the weeks leading up to launch and later during landing. Read more about the Axiom Space Mission 4: Kaleo press release
Kaléo was founded 20 years ago with a mission to develop drug-delivery devices that can be trusted by those who depend on them. All medications added to the Space Mission 4 medical kit undergo rigorous review by Axiom Space. Being trusted by Axiom Space to ensure the Ax-4 Mission crew had access to a trusted epinephrine delivery device is the ultimate responsibility.
Jul 30, 2025
-
Jul 30, 2025
-
Jul 27, 2025
-
AMP announced the recipients of its 2025 Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership and Meritorious Service Awards.
Jul 27, 2025
-
Kephera Diagnostics announced the launch of EndomTest™, the first non-invasive commercially available diagnostic test for endometriosis in the United States. This test only requires a blood sample.
Jul 23, 2025
-
Jul 23, 2025
-
Plug-and-play simplicity meets the demands of modern digital pathology workflows.
Jul 21, 2025
-
Logical Biological announced the launch of a new sister company, Logical Antigen, focused on rapid and customised delivery of high-quality antigens and biologicals, for research and manufacturing of diagnostic products.
Jul 21, 2025
-
his momentum reflects the company’s strong role as a trusted partner to major laboratories worldwide as it helps them to unlock the clinical, operational, and financial value of AI-driven pathology at scale.
Jul 15, 2025
-
Three-in-one system integrates large fragment analytics, DNA size selection and fluorometric quantification for long-read sequencing
Jul 15, 2025
-
VieCure announced a strategic partnership with Guardant Health to embed Guardant’s next-generation sequencing-based precision oncology tests into the VieCure Halo Intelligence platform.
Jul 9, 2025